Trial Search Results
Community Health Workers and Precision Medicine
The purpose of this randomized controlled trial is to evaluate whether a trained community health worker (CHW) who engages with newly diagnosed patients after a diagnosis of cancer can effectively improve knowledge and receipt of evidence-based precision medicine cancer care services among low-income and minority patients.
Stanford is currently accepting patients for this trial.
Collaborator: California Initiative to Advance Precision Medicine
- Behavioral: Community Health Worker Support
- Newly diagnosed patients with a cancer diagnosis.
- Patients with any relapse or progressive disease (any cancer diagnosis) as identified
by imaging or biopsy and confirmed by a physician.
- The patients must be 18 years or older.
- Patients must have the capacity to verbally consent in English or Spanish.
- Patients must be racial/ethnic minorities OR low-income status OR public insurance
(Medi-Cal or other) OR have health insurance provided by an agricultural company OR be
- Patients under 18 years of age.
- Inability to consent to the study due to lack of capacity as documented by the
- Patients without a newly diagnosed malignancy or patients without relapse of disease.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study